Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
阿尔茨海默病和相关痴呆的细胞自主和非自主机制
基本信息
- 批准号:10187414
- 负责人:
- 金额:$ 52.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:3xTg-AD mouseAcuteAdoptedAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAstrocytesBrainCell AgingCell CommunicationCell Cycle ArrestCell modelCellsCerebrumCoculture TechniquesCollaborationsCommunicationComplementDasatinibDementiaDepositionDevelopmentDiseaseElectrophysiology (science)EventExcisionGoalsHippocampus (Brain)HumanHuntington DiseaseImpairmentInflammation MediatorsInterventionLeadMass Spectrum AnalysisMemoryMemory impairmentMicrogliaModelingMolecularMusNatureNerve DegenerationNeurogliaNeuronsOnset of illnessOrganoidsParkinson DiseaseParkinsonian DisordersPathogenesisPathologyPharmaceutical PreparationsPhenotypePhysiologyPlayPost-Translational Protein ProcessingProcessQuercetinRoleSliceSomatic CellSynapsesSystemSystems BiologyWorkage relatedage related neurodegenerationaging brainautocrinebehavioral phenotypingcell typedensityhuman modelin vivoinduced pluripotent stem cellmouse modelpreventprogramsresponsesenescencesingle cell analysisstem cell modelsynaptic functiontau aggregationtau phosphorylationtau-1therapeutic targettranscriptome sequencing
项目摘要
PROJECT SUMMARY
The goals of the Program Project are to understand the causes and consequences of cellular senescence as a
driver of age-related neurodegeneration, determine new targets and mechanisms by which senescent cells drive
disease, and identify new targets for interventions that alter disease onset and/or progression. Project 3 will
explore the cell-autonomous and non-autonomous mechanisms of cellular senescence in Alzheimer's
disease (AD) and related dementia. Senescent astrocytes and neurons displaying senescent-like changes
accumulate in the aging brain, and we hypothesize this is causative in AD. Recent work in Project 1 on mouse
models of Parkinsonism suggests cellular senescence plays a significant role in PD pathology and progression.
A role for senescence in AD is supported by the finding that senolytics (drugs that selectively kill senescent cells)
prevent AD pathology and behavioral phenotypes. We hypothesize that neurons in the brain adopt a cellular
senescent-like phenotype that contributes to AD. We will elucidate key senescent cell types in the brain and
their communication with residing cells that trigger the cascade of events and lead to AD in mouse and human
models of AD. Age-dependent and senescence-driven impairments of neuron function and their responses to
senescent astrocytes or microglia will be examined for their roles in the onset and progression of AD. Therefore,
we will examine proteinopathy-induced neuronal senescence and their response to senescent glia (astrocyte
and microglia). The following Specific Aims are proposed: Aim 1. Determine how neurons become senenscent
like and their response to senescent astrocytes or microglia; Aim 2. Determine if cellular senescence drives
pathology and behavioral phenotypes in mouse models of AD; and Aim 3. Model cellular senescent phenotypes
in human cerebral organoid models of AD. These studies will accelerate the discovery of senescence factors
and downstream targets that influence neurodegeneration and allow us to identify better therapeutics targets for
AD and related dementias.
项目总结
该计划项目的目标是了解细胞衰老的原因和后果
年龄相关神经变性的驱动因素,确定衰老细胞驱动的新靶点和机制
并为改变疾病发生和/或进展的干预措施确定新的目标。项目3将
探索阿尔茨海默病细胞衰老的细胞自主和非自主机制
疾病(AD)和相关的痴呆症。衰老的星形胶质细胞和神经元呈现衰老性改变
在老化的大脑中积累,我们假设这是AD的原因。项目1中关于鼠标的最新工作
帕金森病的模型表明细胞衰老在帕金森病的病理和进展中起着重要作用。
衰老药物(选择性杀死衰老细胞的药物)的发现支持了衰老在AD中的作用。
预防AD病理和行为表型。我们假设大脑中的神经元采用一种细胞
导致阿尔茨海默病的衰老样表型。我们将阐明大脑中关键的衰老细胞类型和
它们与驻留细胞的通讯触发了一连串的事件,并导致了小鼠和人类的AD
AD的模型。年龄依赖性和衰老驱动的神经元功能损害及其对
衰老的星形胶质细胞或小胶质细胞将被检测其在AD的发生和发展中的作用。因此,
我们将研究蛋白质病诱导的神经元衰老及其对衰老的胶质细胞(星形胶质细胞)的反应
和小胶质细胞)。提出了以下具体目标:目标1.确定神经元如何变得有感觉
LIKE及其对衰老的星形胶质细胞或小胶质细胞的反应;目标2。确定细胞衰老是否驱动
阿尔茨海默病小鼠模型的病理和行为表型;以及目的3.模拟细胞衰老表型
在阿尔茨海默病的人脑器官模型中。这些研究将加速发现衰老因素
以及影响神经退化的下游靶点,使我们能够确定更好的治疗靶点
AD及相关痴呆症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa M Ellerby其他文献
Lisa M Ellerby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa M Ellerby', 18)}}的其他基金
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
阿尔茨海默病和相关痴呆的细胞自主和非自主机制
- 批准号:
10491094 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
ADRD Induced pluripotent stem cell/organoid core
ADRD 诱导多能干细胞/类器官核心
- 批准号:
10647771 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
ADRD Induced pluripotent stem cell/organoid core
ADRD 诱导多能干细胞/类器官核心
- 批准号:
10491068 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
细胞衰老和细胞命运/相互作用是阿尔茨海默氏症和年龄相关性痴呆的驱动因素
- 批准号:
10647768 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
Determining the role of OXR1 in aging and Alzheimer's disease
确定 OXR1 在衰老和阿尔茨海默病中的作用
- 批准号:
10461321 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
阿尔茨海默病和相关痴呆的细胞自主和非自主机制
- 批准号:
10647782 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
ADRD Induced pluripotent stem cell/organoid core
ADRD 诱导多能干细胞/类器官核心
- 批准号:
10187409 - 财政年份:2021
- 资助金额:
$ 52.33万 - 项目类别:
Evaluation of the role of RNA toxicity in SCA2 pathogenesis using genome editing in patient iPSCs
使用患者 iPSC 基因组编辑评估 RNA 毒性在 SCA2 发病机制中的作用
- 批准号:
9803833 - 财政年份:2019
- 资助金额:
$ 52.33万 - 项目类别:
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
诱导多能干细胞中模拟人类长寿 ApoE 变异的弹性途径
- 批准号:
9926800 - 财政年份:2018
- 资助金额:
$ 52.33万 - 项目类别:
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
诱导多能干细胞中模拟人类长寿 ApoE 变异的弹性途径
- 批准号:
10417069 - 财政年份:2018
- 资助金额:
$ 52.33万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 52.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 52.33万 - 项目类别:
Operating Grants














{{item.name}}会员




